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This review details the antimicrobial applications of inorganic nanomaterials of mostly metallic 
form, and the augmentation of activity by surface conjugation of peptide ligands.  The review is 
subdivided into three main sections; of which the first describes the antimicrobial activity of 
inorganic nanomaterials against gram-positive, gram-negative and multidrug-resistant bacterial 
strains. The second section highlights the range of antimicrobial peptides and the drug resistance 
strategies employed by bacterial species to counter lethality. The final part discusses the role of 
antimicrobial peptide-decorated inorganic nanomaterials in the fight against bacterial strains that 
show resistance. General strategies for the preparation of antimicrobial peptides and their 
conjugation to nanomaterials are discussed, emphasizing the use of elemental and metallic oxide 
nanomaterials. Importantly, the permeation of antimicrobial peptides through the bacterial 
membrane is shown to aid the delivery of nanomaterials into bacterial cells. By judicious use of 
targeting ligands, the nanomaterial becomes able to differentiate between bacterial and 
mammalian cells and thus, reduce side effects. Moreover, peptide conjugation to the surface of a 
nanomaterial will alter surface chemistry in ways that lead to reduction in toxicity and 
improvements in biocompatibility. 
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Unnecessary and frequent use of antibiotics has caused a worrying and wide-ranging rise in 
bacterial resistance, which has led to serious and life-threatening restrictions in their clinical use 
(Shimanovich and Gedanken, 2016)(Rizzo et al., 2013). Microbes are adept at developing 
antibiotic resistance, and they do this by employing one or more evasive mechanisms. These are 
diverse and include (i) drug target alteration, (ii) enzymatic degradation of antibiotic compounds, 
(iii) efflux-pump of antibiotic molecules from the cell and (iv) biofilm formation (Ahmed, 
Raman and Veerappan, 2016)(Alekshun and Levy, 2007)(Salouti and Ahangari, 2014)(Huang et 
al., 2015; Fidler and Fidler, 2016). Resistance has become serious and is now a global concern.  
It will most likely be responsible for at least 10 million deaths by 2050 (O’Neill, 2014). 
According to the WHO, methicillin-resistant Staphylococcus Aureus (MRSA) infection is fatal 
and multidrug-resistant. Therefore, the development of innovative strategies for combating 
bacterial infection is of pressing need (Wang et al., 2010). The options under investigation for 
addressing this issue are numerous. Among other strategies, antimicrobial peptides (AMP) have 
attracted much interest due to favorable biocompatibility and a low probability of inducing 
bacterial resistance (Baltzer and Brown, 2011)(L. Peng et al., 2016).   
 
AMP works in efficient ways that are not overly specific.  For example, the formation of pores 
may be a general outcome following use with no specificity to bacterial type.  They exhibit a 
range of toxicities to bacteria, fungi, parasites, and viruses. They are capable of bypassing and 
disintegrating into bacterial cell surfaces of multidrug-resistant bacteria (Wang et al., 
2016)(Yount et al., 2006). Some AMP, such as Bactericin and Cap-18, are stable in the presence 
of proteases, elevated temperatures, and pH; properties found to be responsible for a long-term 
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bacterial resistance (Ebbensgaard et al., 2015) (Hassan et al., 2014). Nevertheless, several 
pathogens have developed resistance against antibiotics by modifying the cellular surface, 
expression of efflux pumps, and proteolytic degradation by microbial enzymes (Joo Fu and Otto, 
2016)(Andersson, Hughes and Kubicek-Sutherland, 2016). Therefore, AMP are used as 
commercially available antimicrobials with potential as alternatives to traditional cell wall 
inhibitors, nucleic acid inhibitors, plasma membrane inhibitors, and protein synthesis inhibitors 
(Peters, Shirtliff and Jabra-Rizk, 2010; Tillotson and Theriault, 2013). 
 
Different kinds of inorganic, mostly metal, nanomaterials (NM) have to date been used as 
antimicrobial agents. A significant benefit of metal and metal oxide NM is their various modes 
of action and lack of traditional therapeutic targets, which is why it is challenging for microbes 
to develop resistance against them (Karaman et al., 2017). According to The European 
Commission, NM are materials with at least one external dimension in the size range 1-100 nm. 
In this review, we are going to discuss inorganic nanomaterials with focus on metals and metal 
oxides, and their inherent antimicrobial activity. For instance, to date many different shapes of Au 
and TiO2 NM have been studied as antimicrobial agents (Bhattacharya and Mukherjee, 
2008)(Khan et al., 2011). Furthermore, other metal oxides, such as Copper (II) oxide (CuO), 
Magnesium oxide (MgO), and Zinc oxide (ZnO), exhibit affinity towards the bacterial surface 
and interfere with bacterial integrity. (Bhattacharya and Mukherjee, 2008)(Richards et al., 2000). 
The selective nature of NM in bacterial cells over mammalian cells is due to their differentiated 
perception for these two cells, e.g., from cell wall composition, ribosomes, and Ergosterol 




Although NM show promise for treatments against microbial infections, several essential 
requirements must be met before they can be used for clinical therapies (Casals et al., 2019). The 
first is to address the specific physicochemical properties of NM, such as composition, size, 
crystallinity, and morphology (Kumar et al., 2012) since they are strongly related to the activity of 
NM. Secondly, stable and non-agglomerating NM is engineered to monitor the toxicity. NM has 
a known physical and chemical impact on their toxicity, which can also be severely altered 
depending on their surroundings, for instance, because NM in biological fluids tend to 
agglomerate (Hajipour et al., 2012) (Sutariya et al., 2014). The last one is the biocompatibility of 
NM (Yen, Hsu and Tsai, 2009). The combination of these strategies with AMP allows the 
creation of unique designs that unleashes the promising potential to use the AMP's natural 
functionalities for microbial infections with increased effecacy. 
 
Namely, AMP-conjugated NM can address the disadvantages of free AMP, such as proteolytic 
degradation and low permeability across biological barriers (Rajchakit and Sarojini, 2017b). 
Synergistic behavior can be rendered by amplifying the AMP's anti-microbial strength with that 
of the NM carrier, not only through the conjugation with NM but also, the therapeutic efficacy of 
AMP can be increased. For instance, since AMP can further show selectivity for species, 
researchers have started using NM combined with AMP to carefully release NM from the body 
into the coat of arms where pathogens can be hyperthermally killed (Zharov et al., 2006). 
 
This review illustrates the chemistry, biology, interfacial science, and utilization of AMP-
conjugated NM, not only to hinder the growth but also to kill the bacteria based on their inherent 
action. We will provide the reader with an overview of the antimicrobial mechanisms of action 
9 
 
of inorganic NM, AMP, and their conjugates for antibacterial treatments. This review aims to 
summarise the latest promising findings and propose future approaches for building peptide 
conjugated NM for bacterial infection therapy. 
 
2. NM as antimicrobial agents 
2.1. Mechanisms of action of NM  
NM can exert a beneficial antimicrobial effect due to sub-micrometer scales of size and high 
surface-to-volume ratios. These properties enhance the contact area able to interact with 
pathogens. For this reason, NM exhibit increased biological and chemical activity and can be 
used to target different bacterial structures (Holban and Andronescu, 2016). Figure 1 illustrates 





Fig.1 Different mechanisms of antibacterial action by NM. I) Metal ions released from their respective 
NM electrostatically bind and disturb the phospholipid bilayer of the bacterial membrane, causing 
membrane damage. II) Oxidative stress generated by the membrane disruption responsible for the bacteria 
protein damage. III) ROS is generated by NM, which is accountable for the IIIa) damage of the cell’s 
protein, and IIIb) DNA damage. Protein damage leads to loss of metabolic activity through IV) the 
disruption of the transmembrane electron transport chain. V) Protein damage interferes with fat, 
carbohydrate, protein, and energy metabolism. Adapted with the permission from (Wang, Hu and Shao, 
2017) Copyright © 2017 Dovepress. 
 
Impaired cell membrane function 
Bacterial membranes are negatively charged with a  high binding affinity for positively charged 
metal ions (Lemire, Harrison and Turner, 2013)(Palza, 2015). Several researchers have 
investigated the bacterial toxicity of Ag NM (Yamanaka, Hara and Kudo, 2005)(Sondi and 
Salopek-Sondi, 2004) and Au NM (Yaganza et al., 2004) against E. coli and S. aureus, and 
found that both induce damage to the plasma membrane. Another research by Marius et al. 
(Marius et al., 2011) revealed that Ag NM deposited on the bacterial cell wall surface form 
clusters, leading to bacterial death through cell lysis. Furthermore, Sondi and Salopek-Sondi 
(Sondi and Salopek-Sondi, 2004), as well as Prabhu and Poulose (Prabhu and Poulose, 2012) 
explained that the formation of pores in bacterial cell membranes was due to the NM deposition 
on the bacterial cell surface. Other evidence suggests that the antimicrobial activity of ion release 
from NM surfaces is connected with interruption of the electron transport chain of the membrane 
(Rainnie and Bragg, 1974)(Gordon et al., 2010). For example, micromolar concentrations of Ag
+ 
interact with NADH: ubiquinone oxidoreductase (NQR) enzyme, a component of the respiratory 
chain of bacteria, and inhibit energy-dependent Na
+
 transport resulting in energy depletion and 
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toxicity in bacteria (Hong et al., 2012) 
 
Reactive oxygen species (ROS) production  
NM induce reactive oxygen species (ROS) directly when they interact with aerobically grown 
bacteria, which ultimately leads to necrotic and apoptotic bacterial death (Acker and Coenye, 
2016)(Held and Instruments, 2015). The redox transition of the ROS is carried out using reaction 
mechanisms of Fenton in biologically based systems, including Si, Fe, Cu, Cr, V and Ni. (Huang, 
Wu and Aronstam, 2010)(Kirisits, 2015)(Ubini, 2003)(Tee et al., 2016). Hydrogen peroxide 
(H2O2), which is toxic to biological molecules during the Fenton reactions, oxidizes transition 
metal ions such as Fe
2+
 to produce (HO
-
) and highly relational hydroxyl radicles (OH). 
(Thannickal and Fanburg, 2000). 
 









that can induce different chemical reactions from ROS species (Li et al., 
2010)(Pokhrel et al., 2009). Furthermore, NM can communicate directly with redox active 
proteins such as NADPH oxidase, and stimulate large scale production of ROS in immune cells, 
including macrophages and neutrophils (Manke, Wang and Rojanasakul, 2013). Many recent 
studies clarify the antimicrobial activity of metal NM through the production of ROS. Ag NM 
are well known for their ROS production through surface oxidation or release of Ag
+
 in 
biological medium (Ivask et al., 2010). Moreover, chitosan-coated iron oxide (Fe2O3) NM 
(IONM) also induced significant production of ROS and thus, exhibited bactericidal activity 
against E. coli and B. subtilis (Arakha et al., 2015). Significant intracellular ROS production by 
CuO NM in E. coli was attributed to the release of Cu cations (Ivask et al., 2010)(Meghana et 
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al., 2015). Vijayaraghavan et al. (Padmavathy and Vijayaraghavan, 2008) studied the formation 






 and H2O2, when ZnO NM was in contact with 






2 cannot penetrate the bacterial 
membrane (Xie et al., 2011) and therefore stay in direct contact with the bacteria’s exterior 
surface. In contrast, H2O2 penetrates the bacterial cell wall and causes lipid, DNA, and protein 
destruction (Dutta et al., 2012). Interestingly, halogen adsorption on MgO NM surface induced 
higher antibacterial activity (Blecher, Nasir and Friedman, 2017). The rough surface of NM, the 
oxidative action of adsorbed halogens and strong electrostatic interaction with the negatively 
charged bacterial membrane is a major reason for their excellent antimicrobial activity (He et al., 
2016)(Chen et al., 2014). 
 
Protein dysfunction and loss of enzyme activity 
Several studies have shown that the FeS family of bacteria are susceptible to site-specific 
inactivation by toxic metals, including dihydroxy acid dehydratases (DHAD) and isopropyl-
malate isomerases (IPMIs) involved in branched-chain amino acid synthesizes (Xu and Imlay, 
2012)(Booth, Weljie and Turner, 2015). Moreover, the reduced fumarase A and 6-
phosphogluconate dehydratase activity are one of the most significant toxic effects of Cu, two 
enzymes that also depend upon Fe-S catalysts  (Macomber and Imlay, 2009). It was reported that 
Ag, Hg, Cd, and Zn (but not Mn, Co, Ni or Pb) might harm FeS clusters in vitro and in vivo, 
which contains dehydrates independently of the ROS with bacteriostatic effect. Proteins that 
repair FeS clusters, such as cysteine desulphurase (IscS) or the SufA scaffold protein FeS cluster, 
may restore inactive bacterial enzymes  (Xu and Imlay, 2012). In addition to the destruction of 
FeS clusters, metals are also able to use a route called the ionic simulation to inhibit the site's 
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enzyme. For example, Pb removes Zn from the δ aminolevulinic acid dehydratase (ALAD) 
active site, leading to enzymatic inhibition (Scinicariello et al., 2007) and antimicrobial toxicity 
(Ogunseitan, Yang and Ericson, 2000). Further, Ni can substitute Zn at the non-catalytic Zn site of 
fructose-1,6-bisphosphate aldolase (FbaA) in E. coli, resulting in loss of activity (Macomber, Elsey 
and Hausinger, 2011). 
 
Release of toxic ions  
The antimicrobial efficacy of NM is directly commensurate with the release of ions. Metal ions 
accumulate and pass through cell membranes and intercalate with proteins and nucleic acids 
inhibiting bacterial function (Slavin et al., 2017). For instance, Ag NM can be oxidised by O2 
and other cellular molecules leading to the release of Ag
+
 ions. Ag NM can penetrate the 
bacterial membrane and release Ag
+
 ions, which subsequently bind to amino acids (cysteine) 
affecting their functionality (Hu and Hong, 2017)(Sharma, Kwon and Chen, 2013)(Kanematsu 
and Barry, 2015). Yamanaka et al. (Yamanaka, Hara and Kudo, 2005) used two-dimensional 
electrophoresis to evaluate the influence of Ag
+
 ions on specific proteins in E. coli. Reduced 
expression of 30S ribosomal subunit, succinyl CoA synthetase (SCS), maltose transporter 
(MalK), and fructose bisphosphate aldolase were observed after E. coli incubation with 900 ppb 
Ag
+
 ions compared to the untreated group. The authors sulfurized Ag NM to Ag2S NM and 
found out that sulfidation reduced the release of Ag
+
 ions from Ag NM and reduced their toxicity 
towards E. coli. Similarly, bacterial toxicity of ZnO NM is associated with the dissolution of 
Zn
2+ 
ions within the microbes (Chang et al., 2012)(Ivask et al., 2012). It has been reported that 
the Zn
2+
 ions are toxic towards S. cerevisiae (Kasemets et al., 2009). Similarly, Cu NM exhibited 





Photocatalysis is the excitation of NM, such as Fe2O3, WO3, ZnO, and TiO2, by UV irradiation to 
generate ROS that first damage the lipopolysaccharide layer of the bacterial cell wall, followed 
by the inner peptidoglycan layer. Also, ROS induce peroxidation of lipids and proteins in the cell 
membrane, eventually resulting in organelles leaching from the plasma membrane (PM). TiO2 
has been shown to produce ROS under UV irradiation (Nowack, 2008). High photocatalytic-
mediated antimicrobial activity of TiO2 NM compared to ZnO NM under UV irradiation has been 
observed (Leung et al., 2016). Saito et al. (Saito et al., 1992) used TEM to study the effect of TiO2 
NM and observed disruption of PM of bacteria due to photocatalytic induced ROS. Carre et al. used 
proteomics data to conclude that TiO2 NM can not only down-regulate but also impair membrane 
proteins under UV irradiation (Carré et al., 2014).  Wu et al. studied the photocatalytic activity of 
PdO/TiO2 nanofibers against E. coli (Wu, Imlay and Shang, 2010). The authors reported changes 
in membrane permeability of E. coli, followed by DNA damage upon photocatalytic irradiation 
of PdO/ TiO2.  
 
2.2. NM against gram-positive and gram-negative bacteria 
Difference in composition of the cell wall of gram-positive and gram-negative bacteria affects 
the NM activity. It has been shown that gram-positive bacteria are more resistant to Ag NM than 
gram-negative bacteria. The thick peptidoglycan layer of gram-positive bacteria restricts the 
entry of most of the NM.  However, a study conducted by Ruparelia et al. (Ruparelia et al., 
2008) observed higher antimicrobial activity of CuO NM towards gram-positive B. subtilis, 
which may be due to strong affinity of CuO NM for amine and carboxyl groups. Antimicrobial 
activity of NM may be altered by other characteristics of the NM, like form, size, 
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coating/capping agent, microbial type, surface morphology, crystallinity, and pH (Agnihotri, 
Mukherji and Mukherji, 2014). In this section, will discuss the bacteriostatic and bactericidal role 
of various NM against gram-positive and gram-negative bacteria 
Silver nanomaterials (Ag NM) 
Ag has, for prolonged times, been used as an antimicrobial agent in medicine. It has several 
mechanisms of bactericidal/bacteriostatic effects. As a result, Ag NM are incorporated into 
various consumer goods such as surgical coatings, medical implants, food packaging, textiles, 
and cosmetics. A study, which investigated the size-dependent antimicrobial efficacy of Ag NM on 
gram-positive and gram-negative strains found a significant reduction in bacterial count when 
treated with 5 nm Ag NM on E. coli, B. subtilis, and S. aureus species for 90, 20 and 120 min, 
respectively. Similarly, the reduction of E. coli, B. subtilis, and S. aureus in 180 min was observed 
when treated with 7 and 10 nm Ag NM. The fastest bactericidal effect was observed for the smaller 
5 nm sized NM compared to 7 and 10 nm sized NM, which may be attributed to the higher surface-
area-to-volume ratio of smaller sized NM. The antimicrobial behavior was due to the same 
mechanisms as found by other researchers, such as membrane disruption and interferences. The 
negative charge of citrate-capped Ag NM tended to enable the electrostatic attraction reported in 





Fig.2 FEG-TEM images of E. coli (a) untreated and (b) treated with Ag NM. The inset, as indicated by 
arrows, shows the presence of Ag NM. EDX spectrum (c) demonstrates the presence of.Ag The FEG-
SEM picture (d) confirms the Ag existence throughout the bacterial surface.  Reproduced with the 





Another study comparing the antimicrobial efficacy of different shapes of Ag NM (triangular, 
spherical, and rod) incubated with  E.coli of Ag concentrations 1, 12.5, 50, and 100 µg, concluded 
that triangular and nanosphere forms killed E.coli more efficiently than rods and ionic Ag (Pal, Tak 
and Song, 2015). Triangular Ag NM with an average width of 1 µm was found to produce a 
bacteriostatic effect, and inhibited E. coli 10
6
 colony forming units (CFUs). Considering the 
effect of Ag spheres, almost 12.5 µg Ag was required to reduce E. coli CFUs. In contrast, rod-
shaped and Ag
3+
 were unable to reduce E. coli viability even at 100 µg Ag concentration. This 
experiment further confirms the size and dose-dependent antimicrobial activity of Ag NM. 
Another similar in vitro study investigated Ag-spheres (Ag NM-sp) and Ag-rods (AgNR) on 
gram-positive and gram-negative bacteria using an optical density method. The study reported 
lower MIC values of Ag NM-sp (190,195,188,184,190 µg/ml) than AgNR (358,350,348,320,340 
µg/ml) for S. aureus, B. subtilis, P. aeruginosa, K. pneumonia, and E. coli, respectively. When 
studied against K. pneumonia, different concentrations of Ag NM-sp (184,197,207 µg/ml) and 





 CFU/ml. Cellular viability was reduced to 71.0% and 42.63%, respectively, in the 
presence of 197 µg/ml of Ag NM-sp and 720 µg/ml of AgNR. The higher antimicrobial effect of 
Ag NM-sp over AgNR was attributed to its granular shape with the larger surface area and better 
distribution. 
 
Green synthesis of Ag NM, which are produced from biologically derived moieties, have shown to 
be more toxic than traditionally synthesized Ag NM (Siddiqi, Husen and Rao, 2018). One 
approach of Ag NM synthesis from Ricinus communisvar plant extract has been reported by Bora et 
al. (Ojha, Sett and Bora, 2017). Leave extracts acted as reducing and capping agents to generate 
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spherical Ag NM with a particle size of 30-40 nm. Antimicrobial activity against B. subtilis, S. 
aureus, S. zooepidemicus, E. coli, and E. aerogenes was reported as Ag NM having maximum 
inhibitory activity (MIC 10 µg/ml) against B. subtilis and S. aureus. Ag NM also showed 
antimicrobial activity against E. coli and S. zooepidemicus at 20 µg/ml concentration, while 
showing no cytotoxicity towards mouse fibroblast cells. Another approach observed high 
antibacterial effect of Ag NM synthesized from flower extract of Millettiapinnata against Proteus 
vulgaris, Staphylococcus aureus, Klebsiella pneumonia, E. coli, and Pseudomonas aeruginosa. 
The mode of action for the antimicrobial activity of Ag NM is distinct. First, positively charged 
Ag NM electrostatically adsorbed to the negative bacteria. Subsequently, Ag NM interacts with 
cysteines in protein, which eventually deactivates the protein and releases ROS (Rajakumar et al., 
2017). 
 
Gold nanomaterials (Au NM) 
The bactericidal activity of Au NM is related to their increased penetration into the bacterial cell 
wall, inducing vacuole formation as an indication of the elevated oxidative stress within the 
cytoplasm. For instance, Au NM with an average size of 25 ± 5 nm and surface charge of  -39 
mV were shown to reduce the viability of C. pseudotuberculosis at a concentration of 200 µg/ml 
(Mohamed et al., 2017). Mixed charged (+/-) Au NM were non-toxic to mammalian cells while 
exhibiting selectivity towards different bacterial strains. For example, a positively charged NM 
surface strongly interacts with gram-negative bacteria, whereas negative surface charge has a 
preference for gram-positive bacteria. Wang et al. studied the selective photothermal ablation of 
Salmonella over E. coli using oval-shaped Au NM conjugated with an anti-Salmonella antibody. 
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The authors observed almost 97% reduction of the bacterial viability under irradiation of λ670 nm for 
15 min, whereas E. coli bacteria survived under the same conditions (Wang et al., 2010). 
 
Titanium dioxide nanomaterials (TiO2 NM) 
The evaluation of ROS from the TiO2 NM surface under UV irradiation have shown to exhibit a linear 
correlation between the viability of E. coli and ROS concentration induced after UV irradiation (Li 
et al., 2012). Interactions between superoxide radicals with the unsaturated phosphate lipids in E. 
coli membrane, followed by its lipid peroxidation, was believed to interrupt the cell membrane 




Fig.3 Photocatalytic bactericidal activity of TiO2 based photocatalyst.  
 
However, TiO2NM induce adverse effects on human cells and tissue; hence, their use as 
antibacterial agents remains under limitation (Shah et al., 2017). Doping with Au, Ag, Pt, or Ag, 
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can narrow the bandgap of TiO2 NM and enhance its photocatalytic effect (Ahamed et al., 2017). 
Various reports have described the visible-light-induced antimicrobial activity of Fe, Cu, Ni, and 
Ag-doped TiO2NM against S. aureus and E.coli bacteria (Yadav et al., 2016)(Moongraksathum 
and Chen, 2018). 
 
Copper and copper oxide nanomaterials (Cu and CuO NM) 
In different composite forms of Cu and CuO NM, such as SiO2-Cu, Cu NM were proven to be 
efficient antimicrobial agents against different strains of bacteria (Muthukrishnan, 2015). Bacterial 
membrane destruction was found to be the primary source of bacterial death if subjected to such 
composites. In addition, CuO NM have recently been found to exert a pH-dependent anti-
bacterial effect against S. aureus. CuO NM interact with S. aureus at acidic pH (pH=5) whereby 
significant bactericidal activity was observed due to their lower agglomeration, which facilitates 
solubility dependent release of Cu
2+
 ions compared to pH 6 and 7. The released Cu
2+
 ions induced 
the production of ROS (Hsueh, Tsai and Lin, 2017)(Hajipour et al., 2012). 
 
Cu substituted with hydroxyapatite and fluorapatite (a bone mimetic material) was studied against 
gram-positive and gram-negative bacteria, as well as fungi to overcome possible infection of 
artificial bone implant material after surgery (Shanmugam and Gopal, 2014). In this study, Cu-
substituted hydroxyapatite displayed antimicrobial activity against gram-positive bacteria. In 
contrast, Cu-substituted fluorapatite showed antimicrobial activity not only against gram-positive 
and gram-negative bacteria but also fungi. A higher release of Cu from Cu-substituted-
fluorapatite is the main reason for this intense antimicrobial action. Compared with Ag NM, Cu 
NM are much more potent, and a promising therapeutic with higher colloidal stability and 
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resistance for surface oxidation; being critical factors for Cu NM as antimicrobial agent (Khurana 
and Chudasama, 2018).     
 
Zinc oxide nanomaterials (ZnO NM) 
ZnO displays vigorous antimicrobial activity due to its electrostatic interaction and internalization, 
the release of Zn
2+
 ions, and ROS formation. ZnO NM was proven effective against S. 
typhimurium, C. jejuni, Vibrio fischer, P. aeruginosa, P. alcaligenes, P. vulgaris, S. 
entericaserovar enteritidis, and E. coli (Xie et al., 2011)(Heinlaan et al., 2008)(Jones et al., 2008) 
(Nair et al., 2011)(Nair et al., 2011). The cytotoxic action of  ZnO NM against prokaryotic and 
eukaryotic cells via flow cytometry viability assays concluded that ZnO NM more effectively 
reduced S. aureus and E. coli strains. In contrast, ZnO NM were least effective on human CD4
+ 
T 
cells. Significant reduction of E. coli and S. aureus colonies were observed when >3.4 and 1 mM of 
13 nm ZnO was added to the agar plate. Dose and time-dependent inhibition of bactericidal activity 
was observed for ZnO NM, with entire colonies inhibition after 24 h of treatment. Alternatively, ZnO 
was tested against human T-lymphocytes, whereby no significant reduction of cell viability was 
observed. Overall, these findings display selective antimicrobial activity of ZnO/ZnO NM against 
prokaryotic cells without harming eukaryotic cells (Reddy et al., 2007).  
 
In a study comparing inhibition produced by ZnO, CuO, and Fe2O3 NM against gram-positive (S. 
aureus and B. subtilis) and gram-negative (P. aeruginosa and E. coli), ZnO NM was reported as 
more potent antibacterial agents in comparison to those of Fe2O3 and CuO NM (Yemmireddy and 
Hung, 2017). The antimicrobial mechanism of ZnO NM is believed to be related to particle size, 
which facilitates their bacterial penetration and generation of ROS, being more effective against 
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gram-positive than gram-negative bacteria (Seil and Webster, 2012) (Premanathan et al., 2011). 
For E. coli and S. aureus, the viability was reduced upon the incubation overnight with three nm-
sized ZnO NM at a concentration of 3.1 mg/ml and 1.5 mg/ml, respectively. Gram-positive 
bacteria were more impacted due to the structural differences of the cell wall composition. 
Smaller ZnO NM were able to interact and increase abrasiveness on the bacterial cell wall (Nair 
et al., 2009) (Yuan et al., 2018). 
ZnO NM photoconductivity was reported following UV illumination (390 nm, 1.8 W cm
-2
) ZnO-
rods and ZnO-plates reduced viability of E. coli by 18% (ZnO-rod) and 13% (ZnO-plate), whereas 
the viability of S. aureus was reduced by 22% when exposed to ZnO-rod and by 21% with ZnO-plate 
compared to control. ZnO NM illumination lead to the desorption of loosely bound oxygen 
molecules, thereby increasing its concentration on the ZnO surface, which ultimately generated 




. These ROS inactivate proteins, enzymes, and DNA 
(Ann et al., 2014). In a similar study by Zhou et al. (Zhou et al., 2008) a strong antibacterial rate of 
ZnO complex was obtained in S. aureus (99.45%) due to higher permeability of OH
-
 ions generated 
under UV light through the membrane of S. aureus compared to E. coli (95.65%), whose outer 
lipopolysaccharide (LPS) membrane restricts OH
-
 ions inside E. coli. For microbes, OH
-
ions 
interact with nuclear acids or respiratory classes of sulfhydryl and stop breathing for bacteria. 
The Zn-CuO-coated fabrics benefit from injection into Cu, giving different benefits in contrast to 
ZnO and CuO NM. For example, Zn-CuO NM display 10000 times more antibiotic activity 
within a short time. The potency of antimicrobial bandages, which were prepared by depositing 
Zn-CuO NM on cotton fabric using ultrasound irradiation to exert activity, was evaluated by using 
four microbial models (E. coli, S. aureus, MRSA, and MDR E. coli). Zn-CuO coated fabrics were 
incubated with 10
8
 CFUs for 30 min. 5 and 6 log reduction of E. coli and S. aureus were observed 
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after 10 min of treatment. In contrast, inhibition of only 1 and 2 orders of magnitude was detected 
for S. aureus after ZnO and CuO treatment and negligible effect was observed for E. coli. An 




2, and singlet oxygen formation by Zn-CuO composites resulted in 
higher bactericidal activity compared to ZnO and CuO NM (Malka et al., 2013).  
 
Mesoporous silica nanoparticles (MSNs) 
Silicon dioxide NM, especially so the type of mesoporous silica nanoparticles (MSNs), have 
attracted significant attention as an ideal antibacterial platform (Şen Karaman, Manner and 
Rosenholm, 2018) (Martínez-Carmona, Gun’ko and Vallet-Regí, 2018). Their size, matrix, and 
surface functionality can be adjusted to improve their interaction with bacteria and improve 
biofilm penetration (Camporotondia et al., 2013). Besides, MSNs may also interfere with bacterial 
cell-to-cell communication (quorum sensing) to avoid the development of biofilms. For just over a 
decade, the use of MSNs as effective drug delivery systems, particularly for anticancer therapies, 
has been thoroughly documented. The unique physical features of MSNs (e.g. high specific 
surface areas, large pore volumes and tunable pore sizes), two distinct (external and internal) 
surfaces that can be independently functionalized and further utilised for incorporating controlled 
drug release strategies, and the ability of MSNs to penetrate through biological barriers make 
them compelling candidates for the design of sophisticated antibacterial delivery systems 
(Gounani et al., 2019). Recent studies have reported the usefulness of MSNs for efficient 
antibiotic supply and the preparation of hybrid materials by incorporating MSNs with 
antibacterial enzymes (Li and Wang, 2013), peptides (Braun et al., 2016), metal ions/particles 
(Tian et al., 2014)
 
and polymers (surface modifiers) (Şen Karaman et al., 2016). Moreover, MSNs 
have been developed for dual antibiotic delivery. For instance, recently, Gounani et al. (Gounani et 
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al., 2019) performed the loading of two different antibiotics into MSNs to increase the therapeutic 
efficiency on both gram-positive and gram-negative bacteria. Thus, combinatory therapy with 
dual antibiotic-loaded MSNs could be provided with better treatment results for diseases 
requiring elevated levels of various drugs. 
 
In another study, hollow structured, well-defined mesoporous shells for sustained release of 
entrapped antimicrobial agents were prepared. Such hollow, mesoporous shells not only confers 
stability to the entrapped biological moieties but also acts as a reservoir. For example, amine-
functionalized hollow MSN (HMSN) have shown to act as an efficient carrier for antimicrobial 
agents. When loaded with antituberculosis drug isoniazid, HMSN could release isoniazid in a 
sustained manner (released 60% after 72 h). Isoniazid loaded HMSN exhibited potent 
antimicrobial activity against isoniazid resistant M. smegmatis stain mc
2
 651 (MIC 640 and 320 
ug/mL) and lowered the half inhibitory concentration (IC50) by 3.3- and 4.1-fold compared to 
free isoniazid (MIC 1280 ug/mL) after 24 and 72 h treatment, respectively. The enhanced 
bactericidal activity of isoniazid loaded HMSN may be attributed to increased intra-bacterial 
accumulation of isoniazid in a sustained manner from the well-defined mesoporous shell, 
conjointly with a strong interaction of amine moieties on the HMSN surface with bacteria (Hao 
et al., 2015). 
 
2.3 NM against multidrug-resistant (MDR) bacterial strains 
Multidrug resistance (MDR) developed by certain microorganisms against multiple drugs is a 
leading cause of hospital-acquired infections. It is being assessed that MDR causes 40-60% of 
nosocomial infections in the United States and the United Kingdom (Haque et al., 2018). Metal 
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oxides, metals, doped metals, and metal halides play a vital role in the selective and non-selective 
photothermal killing of MDR (Khlebtsov and Dykman, 2011)(Dizaj et al., 2014). Several metallic 
NM have superior antibacterial activity against MDR bacteria over traditional antibiotics (Blair et 
al., 2015). Bacteria can develop resistance towards metal NM through different mechanisms: 1) 
reduction of metal ions to non-toxic neutral oxidation, 2) increase in efflux of metal ions through 
chemiosmotic antiporters or P-type adenosine triphosphatases, and 3) production of flagellin, a 
bacterial adhesive protein from gram-negative strains, which aggregate metal NM on the bacterial 
surface and reduces antimicrobial efficacy (Nies, 2003)(Li, Nikaido and Williams, 1997)(Gupta et 
al., 1999)(Panáček et al., 2018). Recently, Graves et al. (Siddiqi, Husen and Rao, 2018) observed a 
genetic mutation in E.coli for 225 generations after regular exposure of Ag NM. To date, there have 
been no studies demonstrating the resistance of bacteria towards ROS species. However, most of the 
photosensitisers are water-insoluble and aggregate in water, which ultimately reduces their ROS 
generation capacity. To overcome this issue, a new hydrophobic photosensitiser based on 
amphiphilic block copolymer containing Chlorin e6 (Ce6) conjugated to Au NM surface, have 
shown effectiveness against Staphylococcus aureus (MRSA) (Wijesiri et al., 2017). Table 1 
summarises other metal and metal oxide designs that have been investigated against MDR bacteria.
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Table 1 Antimicrobial activity of metallic NM and metal oxide NM against multi-drug resistant bacteria 
Metal 
NMs 






Investigation under process  
 
Ag containing dressing 
 








Reduce glucose uptake and ATP synthesis, 
production of ROS, alter membrane 
permeability 
 
Ag supported silicate platelets 
 
 










Inhibit respiratory enzymes, binds to DNA and 
RNA and inhibit its replication, denature 30S 
ribosome subunit, alter membrane permeability 
 
           
 








Metal NMs Test MDR Bacteria Mechanism of antimicrobial 
activity 










         Ag 
 
 
Erythromycin resistant Bacillus cereus  
 

















(ESBL) positive E. coli 
 





Generation and uptake of 








(Thapa et al., 2017) 
 
 
MDR P. aeruginosa 
 
Thermal destruction of the 
membrane, ROS generation, 
Penetration of Ag
+
 inside the 
membrane 
 
AgNMs with blue light 
 
 





Metal NMs Test MDR Bacteria Mechanism of antimicrobial 
activity 





Photothermal abilation and 
ROS production 
 
Au Nanorod (Au NR) 
 
 
(Kuo et al., 2009) 
 
 
MDR E. Coli 
MDR E. Cloacae 
MDR K. pneunoniae 
 
Membrane disruption, singlet 







(Khan et al., 2017) 
 
Cu MRSA Cu+ release that damage 
bacterial DNA 
Size-dependent antimicrobial 
activity of CuONMs 




















Meticillin resistant S. agalactiae 
and S. aureus  
penetration and disorganization of cell 
membranes 
NM (Huang et al., 2008) 
CuO MRSA Cu
2+
 ions released from the NMs 
permeate through the bacterial 
membrane and disturb enzyme function 




MDR E. Coli 
MDR S. aureus  
 
Magnetic core under radiofrequency 














Damage of membrane, leakage of 
cellular content, and interacts with 
macromolecules  












ESBL positive E. coli 
 
uptake of NMs inside the membrane and 
damage the biomolecules  










(S. Roy et al., 2010) 
 
UV light-induced ROS generation and 








MRSA Induce immune response NM (Han et al., 2009) 




2.3.1 Antibiotic conjugated NM against MDR 
Metallic NM conjugated with antibiotics can exhibit synergistic antimicrobial activity. As stated 
above in section 2.3, metallic NM may effectively inhibit the viability of MDR bacteria. As a result, 
the potency of antibiotics increases, thereby reducing the side effects towards mammalian cells as 
well as antibacterial resistance (Allahverdiyev et al., 2011). Moreover, metallic NM are suitable 
carriers for the delivery of antibiotics. For example, tetracycline conjugated Ag NM increased 
antibacterial action of tetracycline, due to enhanced accumulation of the Ag
+
 around the bacterial 
cell membranes (Kumar, Curtis and Hoskins, 2018). Similarly, when Au NM was conjugated to a 
fluoroquinolone antibiotic, the antibacterial effects of fluoroquinolone was boosted lowering the 
MIC against MDR bacteria by 8–16 folds compared to free fluoroquinolone; which was due to 
their capacity of conjugates to behave as Tolc-AcrAB efflux pumps (Gupta et al., 2017). Recently, 
Katya et al. (Katva et al., 2018) pointed out the synergistic antimicrobial activity of Ag NM with 
gentamicin and chloramphenicol against MDR E. faecalis compared to antibiotics alone. Several 




 Antibiotic conjugated 
Nanometals 
Test MDR strain Mechanism of antimicrobial action References 
Ampicillin-Ag NMs  
 
Ampicillin resistance E. coli 
Ampicillin resistance P. 
aeruginosa 
Blockage of the efflux pump 
 
(Brown et al., 2012) 
 




Synergistic antimicrobial activity, inhibition 
of protein synthesis, an altercation in the 
respiratory chain 
(Rahim and Mohamed, 2015) 
 
Vancomycin- Ag NMs MRSA Synergistic antimicrobial activity (Saeb et al., 2014) 
MDR E. faecalis  
MDR S. epidermidis  
An altercation of bacterial  permeability (Esmaeillou et al., 
2017)(Panácek et al., 2016) 
Ofloxacin- Ag NMs  
MDR P. aeruginosa 
Inhibition of multidrug efflux pump activity (Ding et al., 2018) 
Tetracycline- Ag NMs 
 
Tetracycline resistance E. coli 
Tetracycline resistance S. aureus 
 














Test MDR strain Mechanism of antimicrobial action References 
Tetracycline- Ag 
NMs 
Neomycin- Ag NMs 
MDR S. typhimurium Antibiotics facilitate binding of Ag NM to 
the bacteria membrane, increase in the 
concentration of Ag
+
 on bacteria membrane 
(McShan et al., 2015) 
 





Antibiotics facilitate binding of Au NM to 
the bacteria membrane, photothermal 
destruction of bacteria cells 







MDR E. coli 
MDR K. Pneumoniae 
MDR S. Aureus 
 
Disorganization and disruption of the 
bacterial membrane, 
loss of intracellular cytoplasmic content 
 
(Pradeepa et al., 2016) 
 
Cefotaxime-Au NMs Cefotaxime resistance E. coli, K. 
Pneumoniae 
Altercation in the bacterial cell wall, DNA 
damage 
 
(Shaikh et al., 2017) 
Meropenem-Au NMs 
 
Carbapenem resistance K. 
Pneumoniae, P. Mirabilis, A. 
Baumanii 
 
Alter osmatic balance and membrane 
integrity, damage of membrane, inhibition 
of protein synthesis 
 







Test MDR strain Mechanism of antimicrobial action References 
Kanamycin-Au NMs 
 
Kanamycin resistance S. Bovis, S. 
Epidermidis, E. Aerogenes 
P. Aeruginosa PA01 
MDR P. Aeruginosa 
Alter cell membrane integrity, lysis of cell 
wall, leakage of cellular content, inhibition 
of protein synthesis 
(Payne et al., 2016) 
 
Vancozycin-Au NMs vancomycin-resistant E. faecium 
(VRE 4), E. faecalis (VRE1) 
MRSA  









Synergistic antimicrobial activity 
 


















MRSA sensitive near-infrared 
fluorescence (NIRF) nanoprobe for 
imaging and photothermal antibacterial 
therapy  
 






2.4 NM against biofilms 
Biofilm is a bacterial cell community that adheres to metals, plastics, and human or animal tissues 
with the aid of highly hydrated extracellular polymeric substance (EPS) matrix (Wingender, Neu 
and Flemming, 1999)(Donlan, 2002). Secreted EPS is responsible for the maintenance of the three-
dimensional biofilm structure (Flemming and Wingender, 2010)(Markowska, Grudniak and 
Wolska, 2013). In a  biofilm environment, bacteria can propagate quickly with efficient protection 
and consequently create 100-1000 times more resistance of the cells towards the phagocytic 
process (Aaron et al., 2002)(Khan and Khan, 2016). Several studies have shown that biofilm-
grown microorganisms acquire resistance by a variety of mechanisms as listed below:  
A) EPS in biofilm acts as a physicochemical barrier and restricts the penetration of antimicrobial 
drugs (Billings et al., 2013)(Tseng et al., 2013). Additionally, an enzymatic substance in biofilm 
matrix hydrolyzes antimicrobial agents and reduces their activity. For example, β-lactamase 
present in  P. aeruginosa degrades β-lactam antibiotics (Mah and O’Toole, 2001)(Ciofu et al., 
2000)(Schooling and Beveridge, 2006). 
B) High-density bacterial growth within a biofilm promotes stress response, which induces the 
production of antimicrobial degrading enzymes (Schembri, Kjaergaard and Klemm, 2003). 
C) Increased DNA exchange between bacteria, which facilitates resistance-gene transmission 
(Qayyum et al., 2016). 
D) By quorum sensing, bacteria are capable of controlling gene transcription (Husain et al., 2016).  
E) The slow growth of bacteria in biofilms is another mechanism of resistance  (Mah and O’Toole, 
2001). 
NM are increasingly regarded as an alternative to standard antibiotics to eliminate biofilms or 
limit their development on biomedical devices (Iannitelli et al., 2011)(Lellouche et al., 2012). 
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Metal NM have a benefit over other frequently used antimicrobials because they do not 
differentiate between pathogenic and drug-resistant microbes with no specific target (Campoccia, 
Montanaro and Arciola, 2013)(Rai, Yadav and Gade, 2009). A diagrammatic representation of 




Fig. 4. Illustration of the inhibition of biofilm formation on surfaces coated by metal NM. Reproduced with 







Fig. 5 Biofilm disrupting the action of metal NM on the pre-formed biofilms. Reproduced with 
permission (Qayyum et al., 2016) Copyright © 2016 RSC Publishing 
 
Several approaches have been developed to eradicate biofilms, bactericidal, and bacteriostatic anti-
biofilm formation (Chen, Yu and Sun, 2013)(Dos Santos Ramos et al., 2018). For example, Ag 
NM have been widely used to prevent biofilm formation for various applications such as catheters, 
dental materials, medical devices, implants, and wound dressings (Wang, Shen and Haapasalo, 
2014)(Thiwawong, Onlaor and Tunhoo, 2013). Secinti et al. (Secinti et al., 2011) studied the anti-
biofilm properties of Ag
+
 ion coated titanium implants against S. aureus biofilm in 20 New Zealand 
rabbits; the result showed that no bacteria or biofilm layer formed on the coated implants, whereas 
biofilm was detected on uncoated implants. Additionally, no Ag
+
 accumulation was observed in 
host tissues (cornea, kidney, liver, and brain) after 28 days post-implantation. However, coating 
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medical devices with Ag
+
 ions or Ag NM sometimes have disappointing results, probably due to 
dose-dependent cytotoxicity (Huang et al., 2016). At optimal concentration, Ag NM is non-toxic 
with low bactericidal effects in mammalian cells (Ewald et al., 2006) (Burd et al., 2007). Han et 
al. (Han et al., 2014) studied the potential toxicity of 20 nm Ag NM in male and female mice in vivo, 
and found a negative impact of Ag NM on the reproduction of mice. Catheters coated with the Ag 
NM reported inducing thrombin formation and platelet activation, resulting in thrombosis (Stevens  
et al., 2009). Recently, Lee et al. (Ramasamy, Lee and Lee, 2017) studied the antibiofilm activity of 
Au NM linked cinnamaldehyde (CNMA-Au NM) and reported significant biofilm inhibition of 
MSSA, MRSA (gram-positive) as well as E.coli (gram-negative) compared to non-conjugated Au 
NM. The smaller size of Au NM and lipophilic nature of cinnamaldehyde facilitated attraction 
between CNMA-Au NM and bacterial membrane within biofilms, which can lead CNMA-Au NM 
to penetrate the biofilm architecture and inhibit biofilm formation by reducing metabolic activity 
and bacterial motility. In a subsequent study, the results demonstrated that cinnamaldehyde 
conjugated with silica (SiO2) coated Au NM (CNMA-Si-Au NM) led to disintegration and 
disorganization of the bacterial membrane, while preserving its integrity when treated with SiO2-
Au NM (silica coated-Au NM). The authors also reported that CNMA-SiO2-Au NM hydrolyzed in 
the acidic pH environment of the biofilm (Mohankandhasamy et al., 2017). 
 
3. Antimicrobial peptides and their antimicrobial potential   
Antimicrobial peptides (AMP) are components of the immune system of many organisms, such 
as bacteria, plants, fish, amphibians, insects, mammals, and even viruses; which not only protect 
them against infections but also display remarkable ability to tune the innate immune responses 
for microbial clearance (Papo and Shai, 2003)(Hancock and Sahl, 2006)(Malmsten, 
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2014)(Etayash et al., 2013). AMP are amphipathic arrangements of 12-50 amino acids, 
categorised into α-helical, β-sheet, extended, and mixed (α & β) with different secondary 




Figure 6. Structural classification of AMP. (A) α-helical, (B) β-sheet, (C) extended, and (D) mixed (α & β) 
peptides. Reproduced with the permission from (Rajchakit and Sarojini, 2017a) Copyright © 2017 ACS 
Publication. 
 
AMP can be aromatic, non-cationic, and anionic peptides; the largest group belonging to cationic 
AMP (Marshall and Arenas, 2003). The α-helical class of cationic AMP has two separate 
characteristics: first, they have a polycationic sequence with a net positive charge (arginine 
and/or lysine) (Wang, Li and Wang, 2009)(Dennison et al., 2005). Positively charged residues 
are the primary driving force for AMP to target anionic membranes of gram-positive and gram–
negative bacteria. Negatively charged moieties (phospholipids, phosphatidylglycerol, cardiolipin, 
phosphatidylserine, and phosphatidylethanolamine) present on the membrane of gram-positive 
and gram–negative bacteria confer electronegativity to the bacterial surface, whereas eukaryotic 
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cells have a neutral net charge on their surface. Cationic AMP are, therefore, ideal for 
prokaryotic cell targeting. 
Additionally, cholesterol in mammalian cell membranes reduces the activity of AMP. AMP retain 
their antibacterial activity in prokaryotic cells, as cells have lower cholesterol levels.  In essence, 
negative surface charge and lack of cholesterol content of prokaryotic membrane attribute for the 
particular bactericidal activity of AMP (Ebenhan et al., 2014)(Zasloff, 2002). Second, the 
common characteristic of all AMP is hydrophobicity (alanine, leucine, isoleucine, valine, 
methionine, phenylalanine, tyrosine, and tryptophan), which is an essential requirement for 
membrane internalization and selective antimicrobial activity. It has been observed that excessive 
hydrophobicity is not only cytotoxic to mammalian cells, but also induces non-selective 
antimicrobial activity. For instance, the increased hydrophobicity of α helical AMP (V13KL) 
resulted in RBC hemolysis, which may have been due to the penetration of AMP deep inside the 
hydrophobic membrane of RBCs. Additionally, excessive hydrophobicity increased the 
dimerization of α-helical AMP (V13KL) and restricted AMP access to through the pathogen 
membrane, which decreased its antimicrobial activity (Chen et al., 2007). In addition to being 
polycationic and hydrophobic, AMP are amphiphilic, with segregated hydrophobic and hydrophilic 
residues, which allows them to be inserted into a pathogen plasma membrane (Cornup et al., 1994). 
 
3.1. Antimicrobial action of peptides 
AMP can affect bacteria by various mechanisms, which are divided into three major classes: 







Membrane disruption  
Bacterial cell wall (CW) provides cellular integrity and stress-bearing ability, and as a result, 
maintains higher osmotic pressure and prevents cell lysis. Due to the bacterial CW composition 
compared to eukaryotic cells, these are a viable drug targeting choice. Among the potential 
targeting ligands are AMP, which display combinatory activity of cell membrane disorganization 
and inhibition of CW formation. AMP self-assembles on the prokaryotic membrane by 
hydrophobic/electrostatic interactions followed by cell membrane disintegration and 
disorganization.  Three different significant models explain the action of AMP: Barrel-Stave 
Model, toroidal pore, and carpet model.  
In the Barrel-Stave Model, parallel orientation of α-AMP on the PM is achieved through 
electrostatic interactions (Huang, 2009), leading to formation of transmembrane pores, which 
leads to cell death through the leakage of ribosome and mitochondrial organelles (Brogden, 
2005)(Yang et al., 2001)(Vedovato and Rispoli, 2007). For example, intestinal C-type lectin 
binds to the peptidoglycan carbohydrate of bacteria and kills it by forming membrane-
penetrating pores (Mukherjee et al., 2014)(Miki, Holsts and Hardt, 2012). 
 
According to the toroidal pore model, AMP accumulates at specific concentrations on the PM 
surface and bends it by increasing the distance between phospholipid moieties, which eventually 
results in a toroidal pore. Subsequently, phospholipids disturb with PM forming pores. In this 
model, unlike Barrel-Stave Model, the lipophilic and hydrophilic arrangement of PM bilayer is 
disorganised. AMP such as magainin-2 (Lee and Aguilar, 2016),  lacticin Q (Lee and Aguilar, 
2016), aurein 2.2 (Cheng et al., 2009), and melittin (Lee and Aguilar, 2016) can self-assemble 
around bacteria in toroidal pore fashion. 
43 
 
In the carpet model, AMP are oriented on the PM to disturb the bilayer in a detergent-like manner 
resulting in micelle formation, causing cell death. Human peptides such as cathelicidin LL-37 
(Shai, 2002), cecropin (Sitaram and Nagaraj, 1999), indolicidin (Rozek, Friedrich and Hancock, 
2000), and aurein 1.2 (Fernandez et al., 2012) can kill different bacteria by carpet mechanism 
(Gable et al., 2009).  
 
AMP often binds to various precursors, which are engaged in CW synthesis. uppP (bacA) genes of 
UppP enzyme, a membrane protein engaged in CW synthesis, is one example of such precursors. 
AMP such as Lactococcin-G and Enterocin-1071 interact with uppP (bacA) genes and inhibit CW 
synthesis (Kjos et al., 2014)(Belguesmia et al., 2017). Likewise, AMP (class I&II) bacteriocins 
bind to the lipid-II, essential for the synthesis of peptidoglycan in gram-positive and gram–negative 
bacteria, and inhibit the formation of CW through pores formation (Islam et al., 2012)(Yount and 
Yeaman, 2013). Some AMP can induce CW production of a lytic enzyme called N-
acetylmuramoyl-L-alanine amidase, responsible for CW wall disintegration and disorganization 
(Wilmes et al., 2014)(Bierbaum and Sahl, 1987). Pep5, nisin, Ɵ-defensin are examples of AMP 
that induce the activity of N-acetylmuramoyl-L-alanine amidase. 
 
Intracellular targets 
Recently, it has been reported that some AMP produce a bactericidal effect by cellular 
accumulation inside the PM targeting intracellular organelles. AMP induce activities such as 
inactivation of bacterial ribosomes, inhibition of protein synthesis, and interference in enzyme 
activity. For example, Bac71-35, oncocin, and apidaecins rich in proline residues that bind to the 70S 
ribosome and block its exit tunnel, eventually inhibits protein synthesis (Gagnon et al., 2016). 
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Buforin-II, a cationic peptide, accumulates and interacts with nucleic acids without interfering with 
the E. coli PM (Park, Kim and Kim, 1998). Interestingly, buforin-II displays anti-endotoxin 
activity, reducing endotoxin generated in gram–negative bacteria (Giacometti et al., 2002). 
Because of the inhibitory effect on endotoxin level, buforin-II prevents multiple organ failure and 
septic shock associated with the endotoxin-induced cytokines production. Microcins, antimicrobial 
peptides from gram-negative enterobacteria, can target intracellular and extracellular pathogens. 
For example, Microcin C (McC) translocates into sensitive cells to reach the target site via 
external membrane porins and internal ABC membrane transporters. In the cytoplasm, McC 
releases non-hydrolyzable aminoacyl adenylate, which obstructs a crucial aminoacyl-tRNA 
synthetase, enzyme for biosynthesis of protein (Fang and Guo, 2015)(Nocek et al., 
2012)(Rebuffat, 2012). Microcidin B17 is a peptide that enables the J25 (MccJ25) micron to 
cross the envelope of the cells, which inhibits DNA replication by inhibiting bacterial RNA 
polymerase (Mukhopadhyay et al., 2004) (Hassan et al., 2014). Haney et al. studied the 
antimicrobial effect of puroindoline derived Pur-B peptide against gram-positive and gram–
negative bacteria (Haney et al., 2013). They found that the positive charge of peptides leads to 
electrostatic attachment to negatively charged membranes. Pur-B peptide further penetrates PM 
and binds to nucleic acids, which ultimately inhibits the transcription and translation process. Gosh 
et al.  found that Indolicidin, an antimicrobial peptide from cathelicidin family, binds and wraps 
around duplex DNA, which leads to transcription inhibition (Ghosh et al., 2014). PR39 is another 
family of cathelicidin peptides with potent antimicrobial activity. This AMP obstructs bacterial 
nucleic acid replication (Bals and Wilson, 2003). This peptide has also been discovered to play a 
crucial role in innate immunity (Veldhuizen et al., 2014). Some studies have observed that PR-39 
inhibits the 20S proteasome in a non-competitive and reversible manner and blocks degradation 
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of NF-kB inhibitor. As a result, NF-kB dependent pro-inflammatory gene expression is 
suppressed in mouse myocardial infarction model and cell culture, thereby reducing 
inflammatory responses (Gao et al., 2000)(Anbanandam et al., 2008). Two bovine bactenecins, 
Bac5 and Bac7, exhibited potent bactericidal activity by obstructing the production of nucleic acid 
and proteins in E. coli and K. pneumonia (Skerlavaj, Romeo and Gennaro, 1990). Interestingly, 
some antimicrobial peptides produced from bacteria, such as bacteriocins, kill the pathogens 
through a receptor-mediated mechanism. 
 
Modulation of Immune Responses 
Apart from direct bactericidal activity, AMP generate different innate immune responses. They 
induce the modulation and expression of multiple cytokines and chemokines, as well as reduce 
inflammation by neutralizing cytokines released from macrophages and monocytes, promoting 
wound repair, modulating the responses of T-cells, and dendritic cells inducing angiogenesis 
(Diamond et al., 2009). Such responses further modulate the innate immunity protecting the host against 
microbial infection. For example, human defensins bind to the CCR6, a protein-coupled receptor, 
and raise the amount of dendritic and T cells at the site of microbial infection. A very low MIC (> 2 
µg/ml) of LL37 in vivo compared to in vitro (32 µg/ml) against E. coli, confirmed the indirect 
antimicrobial activity of AMP in vivo through modulating immune responses (Jenssen, Hamill and 
Hancock, 2006). AMP also recruit phagocytes cells at bacteria-infected sites and modulate 
immune responses against microbial infections. As-CATH2-6, out of six novel cathelicidins (As-
CATH1-6) from Chinese alligator (A. sinensis), showed antimicrobial and immunomodulatory 
activity in a bacteria-infected murine mouse model. As-CATH2-6 generate chemokines and 
recruit neutrophils, monocytes, and macrophages at the microbial infected sites; these 
intracellular granules invade and kill bacteria through phagocytosis (Chen et al., 2017). Likewise, 
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the immunomodulatory role of mammalian host defense peptides (HDP) in combating Leishmania 
infection has also been studied by Rafati et al. (Abdossamadi, Seyed and Rafati, 2016). Upon 
stimulation by pathogens at microbial infected sites, LL-37 promotes the expression of TNF-β and 
IFN-γ from macrophages, promoting pathogen phagocytosis through CD32 and CD64 expression 
(Soehnlein et al., 2008). All these activities promote immune hemostasis. Curiously, AMP stored 
at a sufficient concentration in immune cells, such as NK-cells, mast cells, neutrophils, monocytes, 
and macrophages, are the leading molecules that firstly deal with the pathogens and their expression 
at the infected site regulated by the vitamin-D receptor. Vitamin-D receptor promotes the 
production of vitamins 1,25 D3, which not only induces the expression of AMP but also enables the 
host to acknowledge and react to microbes by CD14 and TLR2 expression (Schauber et al., 
2007)(Liu et al., 2006). Even though the expression of AMP can kill microbes, continuous 
expression leads to autoimmune disorders, such as rosacea and psoriasis (Zhang and Gallo, 2016). 
 
3.2. Resistance to AMP 
Bacteria can develop various types of resistance mechanisms to AMP (Figure 7). Resistance can be 
expressed, for example, by surface remodeling (Hankins et al., 2012)(Malanovic and Lohner, 
2016), modulation of gene expression of AMP (Sperandio et al., 2008) biofilm formation (Yeaman 
and Yount, 2003), proteolytic degradation (Kooi and Sokol, 2009) efflux pumps (Shafer et al., 
1998)(Piddock, 2006)(Bengoechea and Skurnik, 2000), and by lipopolysaccharide (LPS) 
modification (Gunn, 2001). Recently, Cullen et al. (Cullen et al., 2015) reported a gene to induce 
dephosphorylation of LPS, which reduces the net negative charge on the bacterial membrane; as 
a result, the pathogen resists AMP by decreasing their electrostatic interaction with PM.  It is 
worth mentioning that the anionic lipid bilayer structure of bacterial outer membranes interacts 
with the positive charge of AMP, resulting in rapid destruction of the bacterial membrane 
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(Diehnelt, 2013). Additionally, reduced propensity to develop resistance against AMP compared to 
common antibiotics have been reported to date (Bahar and Ren, 2013). Figure 7 illustrates the 
overall resistance mechanisms to AMP.  
 
Fig. 7. Diagrammatic illustration of AMP resistance mechanisms: (A) Gram-positive bacteria, resistance to 
AMP occurs by D-alanine and L-lysine alteration of phospholipids by teichoic acids. (B) Gram-negative 
strains exhibits resistance towards AMP via altering lipopolysaccharide molecules with aminoarabinose or 
acylation of   Lipid A   unit of lipopolysaccharide molecules. (C) Bacteria release proteins (+ charged) that 
integrate with the membrane, and positively charged bacterial membrane can regulate cationic AMP. (D) 
Bacteria induce the formation of negatively charged proteins secreted to bind and block AMP in the 
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extracellular environment. (E) The intracellular AMP are squeezed out by efflux pumps. (F) The AMP 
within the cell are susceptible to degradation by proteases.  
 
 
4. Inorganic NM as carriers for AMP 
Although AMP display broad-spectrum antimicrobial activity, they are rapidly degraded by 
proteases of bacteria and human defense cells, resulting in the loss of their antimicrobial 
efficacy. When administered intravenously, AMP are rapidly cleared from the circulatory system 
and deposition in the reticuloendothelial system (RES). AMP in the RES display loss in 
antimicrobial activity and increase in systemic toxicity (Singh et al., 2014)(VanderVen et al., 
2015). Consequently, especially inorganic NM have gained significant interest lately as potential 
carriers of AMP, which confer protection against chemical and enzymatic degradation, 
controlled release possibilities, enhanced potency and reduced systemic toxicity of encapsulated 
or surface-immobilised AMP (Almaaytah et al., 2017). 
4.1. Inorganic NM for the delivery of loaded AMP 
The well-defined nanometer pores of MSNs allow active packing of AMP and further control of 
their release at the target site. Loading and release kinetics of entrapped drug/biological moieties 
inside MSNs can be regulated by varying surface properties and pore size (Bharti et al., 2015). 
Adsorption of AMP to mesoporous silica was found to be regulated by the pore size and AMP 
concentration in solution. At low AMP concentration, AMP's dimer form strongly adsorbed into 
mesoporous silica with the same pore size as that of the AMP dimer through multivalent peptide-
silica interactions (Braun et al., 2017). However, at higher AMP concentration, formation of 
trimer and tetramer forms of peptides showed higher affinity for the pore walls and outer surface of 




The adsorption of AMP did not occur due to the low peptide-silica interaction that demands 
larger peptide aggregates to enhance adsorption. Peptides adsorbed onto small-sized MSN 
exhibited a faster release rate compared to that of peptides absorbed onto larger MSNs (Braun et 
al., 2017). Likewise, Lzquierdo-Barba et al (Izquierdo-Barba et al., 2009) compared the release 
behavior of high molecular weight LL-37 with low molecular weight chlorhexidine from silica 
monoliths and reported slow-release (~200 h) of both antimicrobial compounds. The release rate of 
such antimicrobials can be altered through the conjugation of the thiol group to the pore wall of silica 
monoliths. Furthermore, both LL-37 and chlorhexidine containing mesoporous silica monoliths 
exhibited antimicrobial activity against both S. aureus and E.coli , and the monolith containing  LL-
37 displayed low cytotoxicity against human keratinocytes and erythrocytes (Izquierdo-Barba et 
al., 2009). Linden et al. compared anionic MSN(-ve), cationic MSN(+ve), and anionic non-
porous silica nanoparticles (NSP) for loading and discharge of the cationic LL-
37(LLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES) AMP, along with its impacts on 
the antimicrobial effect. MSN(-ve) were found to carry a higher amount of LL-37 compared to 
MSN(+ve) and NSP, and conferred protection to AMP against degradation by proteases. 
Interestingly, though less in quantity, cationic LL-37 non-electrostatically adsorbed onto 
MSN(+ve), which might happen due to the reduction of positive surface charge. When studied 
adsorption of these NM on anionic DOPE/DOPG (dioleoylphosphatidylethnolamine/ 
dioleylphosphatidylglycerol) bilayers, a bacteria-mimicking PM, it was found that MSN(-ve) 
neither adsorbed nor disturbed DOPE/DOPG bilayers unless it was loaded with LL-37 AMP. At the 
same time, NSP because of high –ve charge on their surface obtains a resilient LL-37 coating, 
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exhibited low AMP release (Jacob, 2016). Like NSP, MSN(+ve) displayed particle mediated 
membrane disruption but also exhibited toxicity against erythrocytes (Braun et al., 2016). 
Further addressing SiO2 NM as sustained delivery vehicles of AMP, Johnson et al. studied the 
diffusion of AMP from bioinorganic Si-ANM. They were reported to release the entrapped 
cationic decapeptide, KSL (KKVVFKVKFK), in a sustained manner over 5 days. Interestingly, 
released KSL was found to be identical to its free form and retained antimicrobial activity. After 5 
days of diffusion study, when Si-ANM had undergone antimicrobial assay against S.aureus and S. 
epidemidis, no antimicrobial effects were observed (MIC> 225 µg/mL). Furthermore, the trypsin 
digestion assay revealed that free KSL was degraded entirely, whereas KSL recovered from Si-
ANM after trypsin treatment was intact and active. These results show that SiO2NM not only 
confer protection to KSL against proteolytic degradation, but also facilitate sustained release of 
AMP. Sustained release of AMP over extended periods is an essential requirement for implant-
associated infection, i.e. inhibition of bacterial growth or biofilm formation on the device surface 
(Eby, Farrington and Johnson, 2008). 
4.2. Inorganic NM for the delivery of the surface conjugated AMP 
The biomimetic mimicry, a novel approach for precise drug delivery, where biomolecules are 
conjugated on NM surfaces is one of the new frontiers in material research to solve the 
limitations associated with metal NM (Lee, Ashe and Laurencin, 2014). Surface conjugation of 
biomolecules to NM confers stability, prevent agglomeration, attenuate toxicity, prolong the 
circulation time, and increase biocompatibility (Baptista et al., 2013). For example, lysozyme 
incorporated with TiO2 NM protect it from denaturation and confer functional properties to the bio-
nanocomposite (Luckarift et al., 2006). Magnetic FeO NM were also used as carriers for delivery 
of significant biomolecules as depicted in Figure 8, such as peptides (Veiseh et al., 2009), 
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antibodies (Tsourkas et al., 2005), aptamers, DNA (Josephson, Manuel Perez and Weissleder, 
2001), and RNA (Reimhult, 2013) according to five different strategies: 
 
A] Ligand binding through chemisorption of thiol groups onto the exterior surface 
B] Electrostatic adsorption of opposite charges 
C] Covalent binding by compatible functional groups 
D] Non-covalent bonding, e.g. biotinylated oligonucleotides conjugated to streptavidin-Au NM  





Fig.8. Five general strategies of peptides-NM generation: (i) Electrostatic interaction between the surface of 
the NM and the peptide to induce peptide assembly; (ii) Direct binding to NM surface; for example, direct 
binding of free thiols with the surface of Au NM. (iii) These strategies can modify the peptide surface so that 
it can specifically interact to form biotin−streptavidin complexes. (iv) Direct covalent attachment, by 
utilizing chemistry such as 1-ethyl-3-(3-dimethyl aminopropyl)-carbodiimide (EDC)-based coupling of 
amines to carboxyls; (v) Encapsulation of peptide inside the NM matrix.  




4.3. Antimicrobial applications of AMP-conjugated inorganic NM 
In this section, examples of recent research on AMP conjugated NM as antimicrobial agents are 
reviewed. In general, peptides exhibit a lower degree of toxicity and immune response than to high-
molecular-weight polymers, such as polyethyleneimine (PEIs), which are easily degraded in the 
body by enzymes (Xue, Liu and Wong, 2014). Few of these peptides have been proven to have a 
specific binding affinity for cells. Conjugation of NM with these peptides not only elevate their cell 
uptake but also enhance their cellular localization (Liu et al., 2007)(Nativo, Prior and Brust, 
2008). For example, chemical functionalization of the TAT-derived peptide (Chem, 1997) on other 
biomolecules such as proteins (Fawell et al., 1994), small interfering RNA (siRNA)(Turner et al., 
2007), and liposomes (Pappalardo et al., 2009) facilitates their cellular uptake. Furthermore, Tat-
derived peptides act as carriers to facilitate delivery of proteins (Schwarze et al., 1999), QDs (Stroh 
et al., 2005) and polymeric micelles (Liu et al., 2008) to the central nervous system (CNS), because 
of their capability to cross the blood-brain barrier (BBB)(Alyautdin et al., 2014). Moreover, as 
described in section 3.1., peptide-NM are involved in cellular uptake in phagocytic immune cells 
and innate immune responses (Yang et al., 2016). Recent literature has also indicated that 
antimicrobial activity against gram-positive bacteria is exerted by cationic NM created by 
amphiphilic peptide self-assembly (Niño-Martínez et al., 2019). This amphiphilic peptide, 
C17H35GR7RGDS NM, contained seven arginine residues that facilitated membrane translocation 







AMP functionalized Au NM 
Ferreira et al. observed high antimicrobial activity by peptide-conjugated Au NM (CM-SH-Au 
NM) against  E. coli (Ferreira et al., 2016). The in vivo antimicrobial potency of CM-SH-Au NM 
was tested in murine wounds, topically infected with gram-positive and gram–negative bacteria. 
Animals treated with CM-SH-Au NM were found to have a significant attenuation in bacterial 
count. Furthermore, in vivo biodistribution study revealed that less than 5% of Au NM was 
deposited in the spleen, liver, lung, and kidney. The researchers concluded from the in vitro and in 
vivo results that CM-SH-Au NM has promising antibacterial potency. A disadvantage of AMP, 
when decorated onto Au NM, is induction of precipitation of the Au NM. Consequently, in this 
case, AMP on the Au NM surface is insufficient for antimicrobial activity. In contrast, AMP 
conjugation onto Au NM surfaces via the reduction of Au(III) in the presence of side-chain 
protected N-terminus Cys containing peptide and NaBH4, confer secondary α-helical structure 
upon AMP-conjugated Au NM interacting with the bacterial membrane. As a consequence, the 
desired antimicrobial effect is preserved, as shown in Figure 9.  
 
Fig. 9. Illustration of AMP conjugated onto the Au NM surface (B). Conjugates adopt secondary α-helical 
structure upon contact with bacterial membranes to exhibit antimicrobial property (C). Any attachment of  
Lys with the Au NM leads to precipitation of Au NM (A). Reproduced with permission  from (Wadhwani et 




AMP-Au NM conjugates confers AMP stability against protease degradation and enhances the 
AMP half-life for up to 24 h. Interestingly, it was reported that AMP-Au NM retained similar 
activity as the free AMP in an aqueous buffer against both gram-positive and gram–negative 
bacteria (Wadhwani et al., 2017). Chang et al. evaluated the antimicrobial efficacy of 1- 
dodecanethiol (DT) and Surfactin (SFT) immobilised gold nanodots (SFT-DT-AuNDs). They found 
>80-fold lower MIC compared to SFT and DT-AuNDs against MRSA stains. These effects were 
correlated to synergistic bacterial membrane damage by SFT and DT-AuNDs. Besides, hemolysis 
and cytotoxicity assays revealed higher biocompatibility of SFT-DT-AuNDs than free SFT. Lee et 
al. studied the efficacy of Au NM-Apt (Au NM conjugated with DNA aptamer) for efficient 
delivery of C-terminally hexahistidine tagged A3-APO
His
 peptide into S. typhimurium infected 
mammalian cells (Yeom et al., 2016). Changes in the morphology of S. typhimurium cells were 
observed when the cells were treated with A3-APO and A3-APO
His
peptide. SEM analysis showed 
disruption of PM when incubated with A3-APO
His 
whereas A3-APO did not affect the membrane. 
Besides, the SYTOX assay disclosed that A3APOH caused S. Typhimurium internal PM 
disturbance resulting in increased SYTOX green fluorescence intensity due to binding of the 
cationic dye to the nucleic acid. S. typhimurium-infected HeLa cells were used to test the 
antimicrobial potency of Au NM-AptHis-A3-APO
His
. The result showed that the number of 
intracellular S. typhimurium cells was found to be 30-50% less when treated with Au NM-AptHis-
A3-APO
His
 than those treated with Au NM-Apt
His
, which exhibits negligible effects on S. 
typhimurium viability. Because all the S. typhimurium infected mice after intravenous 
administration of Au NM-AptHis-A3-APO
His 
 survived, it was concluded that Au NM-Apt is more 
efficient in removing intracellular S. typhimurium cells both in vitro and in vivo without inducing 
toxicity to healthy mammalian cells. 
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AMP functionalized Ag NM 
Metal/metal oxide NM can impart new functionality and reactivity to the new compounds, which 
can lead to promising bactericidal effects against multidrug-resistant bacteria (Chaloupka, Malam 
and Seifalian, 2010)(Kalishwaralal et al., 2010). For example, bivalent Ag NM conjugated with 
histatin-1, an AMP that is involved in re-epithelialization processes (Oudhoff et al., 2008), has 
shown promising MIC values (around 1 mg/L) against gram-positive and gram–negative bacteria 
with potent wound healing properties (Pal et al., 2014)(Pal et al., 2014). Ag NM at a certain 
concentration is known to be toxic to mammalian cell lines (Skalska and Strużyńska, 2015). 
Surface modification of Ag NM with AMP reduces the toxicity of Ag NM and enhances stability 
and antimicrobial activity. For instance, the strong interaction of positively charged non-cysteine 
containing AMP with Ag NM (Liu et al., 2013) can disturb the conformation of AMP, resulting in 
decreased antimicrobial efficacy. Therefore, the main parameter in the design of new conjugates 
is the balance of stability/strong interaction for achieving optimal antimicrobial activity. The Ag 
NM and resultant AMP-Ag NM conjugate have shown enhanced stability and antimicrobial efficacy 
in comparison to the Ag NM and AMP alone. When the antibacterial mechanism of AMP-Ag NM 
was studied, conjugates disturb bacterial PM more significantly compared to AMP alone. 
Furthermore, fluorescence-activated cell sorting (FACS) assay has been used to measure bactericidal 
potency of AMP, AMP-Ag NM, and Ag NM. Results of bacterial cell death revealed synergistic 
antimicrobial activity AMP-Ag NM (60% dead cell population) compared to Ag NM (31%) and 
AMP (33%), respectively. This study concluded that Ag NM, due to its negative charge, was unable 
to interact with PM and confirmed that AMP on the Ag NM surface is responsible for bacterial PM, 
damage followed by the arrest of transcription and translation (Pal et al., 2016). Similarly, Liu et. 
al. showed that conjugation of AMP with Ag NM elevate their bactericidal effect compared to 
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unbound AMP, and enhanced the biocompatibility of Ag NM compared to using the Ag NM 
alone (Liu et al., 2013). Navani et. al. (Lambadi et al., 2015) found ~3- fold antibiofilm activity 
increase of Polymyxin-B conjugated Au NM (PBAu NM) compared to citrate-capped Au NM. 
The result revealed that the antimicrobial activity of PBAu NM coated surgical blades was 
enhanced compared to citrate-capped Au NM and uncoated surgical blades. This was due to highly 
cationic Polymyxin-B on the Au NM surface. The result of in vitro antimicrobial assay, live/dead 
staining, and flow cytometry are also in agreement with the elevated antimicrobial activity of PBAu 
NM against P. aeruginosa. 
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5. Conclusion and perspectives 
The bactericidal efficiency of various NM, antimicrobial peptides, and peptide conjugated NM 
against different bacterial strains have been provided in this review. In general, the antimicrobial 
activity of nanometals, AMP, and antimicrobial peptide conjugated NM depends on the bacterial 
cell surfaces and NM conjugation characteristics. The biomimetic properties of AMP assist the 
targeted delivery of peptide conjugated NM, whereas ions released from NM kill microbial 
pathogens. However, further studies should elucidate the precise mechanism of metal ions, 
whether membrane disturbance or cytoskeleton detachment from the plasma membrane is 
causing cell death. Most of the antimicrobial properties have to date been tested against E. coli 
and S. aureus. To demonstrate the wide variety of bactericidal/bacteriostatic characteristics of 
peptide conjugated NM, it will be essential to explore other pathogenic species and phenotypes. 
In comparison to bacteria, there are very few reports on the antifungal properties of antimicrobial 
peptides. Some studies have demonstrated that covalent surface modification with exposure to 
oxygen or the presence of UV can create rapid cytotoxicity. Therefore, toxicity should also be 
studied under circumstances of UV and air exposure. It has also been found that different 
physical and chemical parameters of NM, such as size, shape, surface-to-volume ratio, the 
surface charge of the particles, and their synthesis methods influence their antibacterial 
efficiency. For example, Ag NM with the same surface areas but with distinct shapes may have 
different bactericidal activity against pathogens. Thus, the antimicrobial effects of AMP 
conjugated to NM with different physicochemical characteristics against different bacterial 
strains should be the next line of research. One major limitation for advancements of peptide 
conjugated metal NM is that in vivo and in vitro antimicrobial activity do not discriminate 
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whether peptide conjugated NM can kill pathogenic microorganisms selectively without 
influencing healthy mammalian cells. In this scenario, the study of the interaction of various 
shapes of NM on mammalian cells should be carried out. Moreover, non-metals such as Ag and 
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